Member Info for AndytheMKDon

Hey Aber. They are not all sells there’s plenty of buys that went through below the mid earlier. There’s a lot more to the current trading pattern than the Pfizer vaccine news. I hope a bit of rogue news from China catches a few with shorts down. Probably a lot of CFD’s and spread bets need closing.

You’ll know if they’ve earned their salaries when a deal for 1801 / 1802 is signed or Sar is taken over. Then and only then will the value of their input be known.

As stated below. Same company with the same prospects as last week. For the dissenters trying to talk it down don’t wait too long for your re entry point!! !!!

What’s up?? I’ll tell you what’s up. Disingenuous buggers wanting a lower entry price. The same ones who were singing the praises of the company last week. Very sad people.

Nothing has changed in Sar. We have the same products looking to address the same illnesses as we were last week and are expecting the same news flow and progress which is well documented. Sar didn’t become a bad company because Pfizer developed a vaccine.

Even the market maker won’t kill the goose. They’ve rung it out all the way down then the reversal will come. Just waiting for the bounce.

I emailed LSE today regarding the problems with the share chat and they replied immediately to say that their system can't support live streams and chat at present so they have turned off chat during trading times to allow their members to stream live data, they did however say they were working on a fix asap. I hope this is the case as it's difficult to share information, i've reverted to using advfn share chat as i have live platform their however there's not many posters so a bit dull. I see it was an uncrossing trade which moved the sp to an unlikely 1.5p close when reallity looked like 1.25p. I've added some today given what looks like a totally oversold stock on grounds of a vaccine which isn't really core to our business. Lets hope the mm stops buggering around tomorrow and restores the sp to where it should be i.e. north of 2p. gla. Andy.

As T2 mentioned if you cut through the chaff today Sar tweeted the success BMS are having with their Tyk2 which further strengthens the validity of 1801 and 1802. As also posted people have fallen into th trap of thinking Sar is a covid play when in fact covid is an adjunct to our core business. We should expect a pretty firm bounce in the morning once the real extent of sars strategy is understood by those other than long term holders. Finally it's a shame that upon a day when the ability for investors to exchange information was so important that LSE were once again unable to provide a service, I suspect this had an effect of compounding the fall in sp due to new investors being unable to be assured of the real events surrounding sar, let's hope at some point they restore some reliabilty to the service they should provide. glalth. Andy.

In TM’s investor presentation they showed 100% tumour reduction after 21 days and 80% tumour free after 60 days with SRA737. Can’t imagine it won’t go into PIII. Nice weekend all. See you Monday. :+)

When challenged as to when and if vaccines would be available even the goverments chief scientific officer fessed up yesterday on TV to say it's not all about vaccines and that a three pronged attack would include therapeutics and extensive testing. So finally even the government are waking up and understanding the important role that products like Tyk2 Jak1 will play as part of the long term solution to Covid. As we all know SDC1801 / 02 are about a lot more than just Covid. You wouldn't want to be out of this over the weekend... lol.. gla. Andy.

RMM.. Great find and good observations. Eventually investors and Insti's will twig on that this is the sort of asset value Sar have with Tyk2. We are in a very hot area and are one of only a couple of company's who have a viable product. Shouldn't be long to wait now with SDC1801 and 1802 due to enter the clinic in the coming weeks / month's. 1801 in Covid / 737 / Aurora could add a nice big dollop of cream onto what will surely be a fairly substantial cake.. gl. Andy.

SOG. I've mailed TM for clarification upon Sierra's comments and also asked when we will receive the readouts from PI PII trials. gl. Andy

My take being: essentially they are saying it needs developing but they can't afford it, enter Gilead stage right imo.

arumel. good find and thanks for posting. My take on their comments is their issue on developing 737 is based upon their ability to fund it, at no point in their comments do they refer to it not progressing due to lack of efficacy or poor results, which I view as a positive. In three sentences they mention development four times. :+)

Tim was quite clear in the recent investor presentation that Sierra intend to develop it in house, he said it unequivocally. So he must know whats going to happen next. It's always been my belief that Gilead will fund Sierra to take it forward. gla. Andy.

Big pharma price’s have gone up loads on the back of a potential Trump loss. He was trying to cap price’s of generic drugs. Markets are well up too. Looks like the stock market’s will be glad to see the back of him and his adversarial global policies. !! Come on Sar step up. ;+)

Hello SOG.. As you say something needs to give soon or else CRT need to hook it back. gl fella. Andy.

Maybe we'll get some good news from over the pond.. If their 10 Q doesn't come today it'll most likely be tomorrow, if there was bad news in there for their share price, then what better day to hide bad news than today given th US election debacle. gla. Andy.

There seems to be a buyer sat on the ask at around 1.80-1.83 buying in 500k lot sizes. Five or six trades so far today at this price. We might expecct to get Sierra's 10Q quartely report today, should get an RNS from them soon if it's going to be released today. gla. Andy.

With a potential lockdown likely to be announced later today and a vaccine looking a long way off, if at all, then the focus on antivirals and autoimmune products becomes more pressing than ever. Our share price could move very quickly as the government scramble for a solution and the news media start to open their gaze towards therapeutics rather than just vaccines. Gla. Andy. :+)